News
-
-
-
PRESS RELEASE
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations
SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations effective August 2024. With his extensive experience in finance and capital markets, Erfurth aims to enhance SCHOTT Pharma's presence in the capital markets -
-
-
-
-
-
-